SPHS - Sophiris Bio Inc.
Previous close
0.23
0.230 100.000%
Share volume: 0
Last Updated: Wed 11 Mar 2020 09:00:00 PM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
46%
Profitability
59%
Dept financing
34%
Liquidity
28%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Sep-2015 - 30-Sep-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
104.18%
Return on assets
-18.34%
Return on sales
0%
Return on invested capital
77%
Total debt ratio
86.29%
Debt ratio change over timeo
-0.16%
Current Ratio
8.72%
Quick Ratio
0%
Cash Position Ratio
4.84%
Short-term ratios 30-Sep-2018 - 30-Sep-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
257.77%
Return on assets
-29.29%
Return on sales
0%
Return on invested capital
3.83%
Total debt ratio
116.7%
Debt ratio change over timeo
0.41%
Current Ratio
1.96%
Quick Ratio
0%
Cash Position Ratio
1.51%
Last quarter ratios 30-Sep-2019
The data are presented for the financials results of the last quarter.
Return on equity
34.73%
Return on assets
-29.95%
Return on sales
0%
Return on invested capital
24.99%
Total debt ratio
138.89%
Debt ratio change over time
1.8%
Current Ratio
1.79%
Quick Ratio
0%
Cash Position Ratio
1.08%
Performance ratios (change over 4 years) 30-Sep-2015 - 30-Sep-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-49.73%
Return on assets
-118.06%
Return on sales
0%
Return on invested capital
-19.85%
Total debt ratio
-15.89%
Debt ratio change over time
-0.16%
Current Ratio
7.34%
Quick Ratio
0%
Cash Position Ratio
1.95%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SPHS | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 104.18% | 0% | 0% | 45.25% |
| Return on assets | -18.34% | 0% | 0% | -8.54% |
| Return on sales | 0% | 0% | 0% | -329.51% |
| Return on invested capital | 77% | 0% | 0% | 34.02% |
| Profitability | 75% | 0% | 25% | 22% |
| Total debt ratio | 86.29% | 0% | 0% | 210.62% |
| Debt ratio change over time | -0.16% | 0% | 0% | 23.76% |
| Dept financing | 10% | 0% | 0% | 50% |
| Current Ratio | 1.96% | 0% | 0% | 4.71% |
| Quick Ratio | 0% | 0% | 0% | 4.71% |
| Cash Position Ratio | 1.51% | 0% | 0% | 4.63% |
| Liquididy | 50% | 0% | 0% | 51% |
| Short-term ratios | SPHS | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 257.77% | 0% | 0% | 156.31% |
| Return on assets | -29.29% | 0% | 0% | -10.48% |
| Return on sales | 0% | 0% | 0% | -390.03% |
| Return on invested capital | 3.83% | 0% | 0% | 59.25% |
| Profitability | 52% | 0% | 25% | 40% |
| Total debt ratio | 116.7% | 0% | 0% | 108.54% |
| Debt ratio change over time | 0.41% | 0% | 0% | 0.53% |
| Dept financing | 44% | 0% | 0% | 48% |
| Current Ratio | 1.96% | 0% | 0% | 4.71% |
| Quick Ratio | 0% | 0% | 0% | 4.71% |
| Cash Position Ratio | 1.51% | 0% | 0% | 4.63% |
| Liquididy | 19% | 0% | 0% | 75% |